BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 8116579)

  • 1. Evaluation of the PAPNET cytologic screening system for quality control of cervical smears.
    Koss LG; Lin E; Schreiber K; Elgert P; Mango L
    Am J Clin Pathol; 1994 Feb; 101(2):220-9. PubMed ID: 8116579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy.
    O'Leary TJ; Tellado M; Buckner SB; Ali IS; Stevens A; Ollayos CW
    JAMA; 1998 Jan; 279(3):235-7. PubMed ID: 9438746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant reduction in the rate of false-negative cervical smears with neural network-based technology (PAPNET Testing System).
    Koss LG; Sherman ME; Cohen MB; Anes AR; Darragh TM; Lemos LB; McClellan BJ; Rosenthal DL; Keyhani-Rofagha S; Schreiber K; Valente PT
    Hum Pathol; 1997 Oct; 28(10):1196-203. PubMed ID: 9343327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural-network-assisted analysis and microscopic rescreening in presumed negative cervical cytologic smears. A comparison.
    Mango LJ; Valente PT
    Acta Cytol; 1998; 42(1):227-32. PubMed ID: 9479345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative cervical smears before CIN 3/carcinoma. Reevaluation with the PAPNET Testing System.
    Doornewaard H; van de Seijp H; Woudt JM; van der Graaf Y; van den Tweel JG
    Acta Cytol; 1997; 41(1):74-8. PubMed ID: 9022729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and outcomes of PAPNET secondary screening technology for cervical cytologic evaluation. A community hospital's experience.
    Brotzman GL; Kretzchmar S; Ferguson D; Gottlieb M; Stowe C
    Arch Fam Med; 1999; 8(1):52-5. PubMed ID: 9932072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated screening for quality control using PAPNET: a study of 638 negative Pap smears.
    Keyhani-Rofagha S; Palma T; O'Toole RV
    Diagn Cytopathol; 1996 Jun; 14(4):316-20. PubMed ID: 8725131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of PAPNET: review of 25,656 Pap smears negative on manual screening and rapid rescreening.
    Halford JA; Wright RG; Ditchmen EJ
    Cytopathology; 1999 Oct; 10(5):317-23. PubMed ID: 10588350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the PAPNET system in a general pathology service.
    Farnsworth A; Chambers FM; Goldschmidt CS
    Med J Aust; 1996 Oct; 165(8):429-31. PubMed ID: 8913244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer-assisted rescreening of clinically important false negative cervical smears using the PAPNET Testing System.
    Rosenthal DL; Acosta D; Peters RK
    Acta Cytol; 1996; 40(1):120-6. PubMed ID: 8604564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAPNET analysis of reportedly negative smears preceding the diagnosis of a high-grade squamous intraepithelial lesion or carcinoma.
    Sherman ME; Mango LJ; Kelly D; Paull G; Ludin V; Copeland C; Solomon D; Schiffman MH
    Mod Pathol; 1994 Jun; 7(5):578-81. PubMed ID: 7937724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality control of cervical cytology in high-risk women. PAPNET system compared with manual rescreening.
    Bergeron C; Masseroli M; Ghezi A; Lemarie A; Mango L; Koss LG
    Acta Cytol; 2000; 44(2):151-7. PubMed ID: 10740599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescreening of atypical cervicovaginal smears using PAPNET.
    Lerma E; Colomo L; Carreras A; Esteva E; Quilez M; Prat J
    Cancer; 1998 Dec; 84(6):361-5. PubMed ID: 9915138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical squamous cells of undetermined significance: a comparative review of original and automated rescreen diagnosis of cervicovaginal smears with long term follow-up.
    Stastny JF; Remmers RE; London WB; Pedigo MA; Cahill LA; Ryan M; Frable WJ
    Cancer; 1997 Dec; 81(6):348-53. PubMed ID: 9438460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAPNET testing for HSILs. The few cell/small cell challenge.
    Solomon HM; Frist S
    Acta Cytol; 1998; 42(1):253-9. PubMed ID: 9479348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The PAPNET system in cytological rescreening of cervical smears].
    Cenci M; Nagar C; Giovagnoli MR; Vecchione A
    Minerva Ginecol; 1997 Apr; 49(4):139-45. PubMed ID: 9206764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PAPNET system for quality control of cervical smears: validation and limits.
    Cenci M; Nagar C; Giovagnoli MR; Vecchione A
    Anticancer Res; 1997; 17(6D):4731-4. PubMed ID: 9494597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The PAPNET system in the rescreening of negative cervical/vaginal smears. A study from the Imola cytology laboratory].
    Ghidoni D; Fabbris E; Folicaldi S; Amadori A; Medri M; Bucchi L; Bondi A
    Pathologica; 1998 Aug; 90(4):357-63. PubMed ID: 9793395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulation of primary cervical cancer screening by the PAPNET system in an unscreened, high-risk community.
    Michelow PM; Hlongwane NF; Leiman G
    Acta Cytol; 1997; 41(1):88-92. PubMed ID: 9022732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assurance in cervical cytology screening. Comparison of rapid rescreening and the PAPNET Testing System.
    Halford JA; Wright RG; Ditchmen EJ
    Acta Cytol; 1997; 41(1):79-81. PubMed ID: 9022730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.